COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign

Re-analysis of the Pfizer trial data identified statistically significant increases in serious adverse events (SAEs) in the vaccine group. Numerous SAEs were identified following the Emergency Use Authorization (EUA), including death, cancer, cardiac events, and various autoimmune, hematological, reproductive, and neurological disorders. Furthermore, these products never underwent adequate safety and toxicological testing in accordance with…

Read More

Top 12 Benefits of Melatonin

Melatonin has many benefits beyond sleep including immune support, heart health, diabetes, & cancer. Helps optimize mitochondrial health throughout the body and in the brain.Now we know melatonin also improves memory & increases the formation of new brain cells. It also exerts a protective effect on neurons, especially against oxidative stress.While the melatonin sold as…

Read More

Autophagy – Body’s detox process that kills COVID-19 vaccine spike protein damaged cells & reboots immune system

NEW ARTICLE: Vaccine Injury Treatment – Fasting for 48-72 hours creates autophagy – body’s detox process that kills COVID-19 vaccine spike protein damaged cells & reboots immune system mRNA vaccine injured people have damaged immune systems. Fasting creates new immune cells. Autophagy removes cells damaged by spike protein, pre-cancerous cells, senescent cells, damaged mitochondria, protein…

Read More

A Message from Japan to the world

A Message from Japan to the world! Please share and distribute!Thank you very much for giving me this valuable opportunity to send my message about human rights abuse in the time of COVID-19. My name is Masayasu Inoue, Professor Emeritus of Osaka City University Medical School. My specialty is Molecular Pathology and Medicine. The pandemic…

Read More

Ancient Chinese medicine unlocks new possibilities for cancer treatment

Ancient Chinese medicine unlocks new possibilities for cancer treatment After 20 years of research, Yale pharmacologist Yung-Chi Cheng and his partners are launching the first international clinical trial for a botanical drug. More than 20 years ago, Yale pharmacology professor Yung-Chi Cheng, a leader in drug development for hepatitis B, cancer, and HIV, had a…

Read More